Ventyx Biosciences's total assets for Q1 2025 were $253.48M, a decrease of -8.35% from the previous quarter. VTYX total liabilities were $21.85M for the fiscal quarter, a -2.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.